Humana Inc. (NYSE:HUM) Shares Bought by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. raised its stake in Humana Inc. (NYSE:HUM - Free Report) by 2.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 125,684 shares of the insurance provider's stock after buying an additional 2,950 shares during the quarter. Envestnet Asset Management Inc. owned about 0.10% of Humana worth $33,256,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of the stock. Retirement Planning Co of New England Inc. lifted its position in Humana by 4.7% in the fourth quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider's stock valued at $245,000 after buying an additional 43 shares during the last quarter. Achmea Investment Management B.V. lifted its position in Humana by 0.5% in the first quarter. Achmea Investment Management B.V. now owns 10,379 shares of the insurance provider's stock valued at $2,746,000 after buying an additional 49 shares during the last quarter. Beech Hill Advisors Inc. lifted its position in Humana by 6.1% in the first quarter. Beech Hill Advisors Inc. now owns 865 shares of the insurance provider's stock valued at $229,000 after buying an additional 50 shares during the last quarter. Deseret Mutual Benefit Administrators lifted its position in Humana by 15.8% in the first quarter. Deseret Mutual Benefit Administrators now owns 462 shares of the insurance provider's stock valued at $122,000 after buying an additional 63 shares during the last quarter. Finally, Vise Technologies Inc. lifted its position in Humana by 8.0% in the fourth quarter. Vise Technologies Inc. now owns 873 shares of the insurance provider's stock valued at $221,000 after buying an additional 65 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Wall Street Analysts Forecast Growth

HUM has been the topic of several research reports. Truist Financial set a $280.00 price target on shares of Humana and gave the stock a "hold" rating in a research report on Tuesday, June 17th. Barclays set a $268.00 price target on shares of Humana and gave the stock an "equal weight" rating in a research report on Thursday, June 12th. Oppenheimer increased their price target on shares of Humana from $300.00 to $310.00 and gave the stock an "outperform" rating in a research report on Thursday, May 1st. Raymond James Financial raised shares of Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price target on the stock in a research report on Thursday, May 1st. Finally, Mizuho increased their price target on shares of Humana from $305.00 to $316.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Seventeen analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $280.76.

Humana Stock Performance

Shares of Humana stock opened at $230.38 on Monday. The firm has a market capitalization of $27.80 billion, a P/E ratio of 16.29, a P/E/G ratio of 1.74 and a beta of 0.44. Humana Inc. has a 52 week low of $212.45 and a 52 week high of $406.46. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.71. The firm's 50 day moving average is $237.78 and its two-hundred day moving average is $258.34.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $11.58 EPS for the quarter, beating the consensus estimate of $10.07 by $1.51. The company had revenue of $32.11 billion for the quarter, compared to analyst estimates of $32 billion. Humana had a net margin of 1.42% and a return on equity of 14.47%. The firm's revenue was up 8.4% on a year-over-year basis. During the same period in the prior year, the firm posted $7.23 earnings per share. Research analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.54%. The ex-dividend date of this dividend is Friday, June 27th. Humana's payout ratio is currently 25.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.